The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Testosterone Suppresses Hepcidin in Men: A Potential Mechanism for Testosterone-Induced Erythrocytosis
Open accessAbstract
CONTEXT: The mechanisms by which testosterone increases hemoglobin and hematocrit are unknown. OBJECTIVE: The aim was to test the hypothesis that testosterone-induced increase in hematocrit is associated with suppression of the iron regulatory peptide hepcidin. PARTICIPANTS: Healthy younger men (ages 19-35 yr; n = 53) and older men (ages 59-75 yr; n = 56) were studied. METHODS: Weekly doses of testosterone enanthate (25, 50, 125, 300, and 600 mg) were administered over 20 wk, whereas endogenous testosterone was suppressed by monthly GnRH agonist administration. Blood and serum parameters from each individual were measured at wk 0, 1, 2, 4, 8, and 20. Longitudinal analyses were performed to examine the relationship between hepcidin, hemoglobin, hematocrit, and testosterone while controlling for potential confounders. RESULTS: High levels of testosterone markedly suppressed serum hepcidin within 1 wk. Hepcidin suppression in response to testosterone administration was dose-dependent in older men and more pronounced than in young men, and this corresponded to a greater rise in hemoglobin in older men. Serum hepcidin levels at 4 and 8 wk were predictive of change in hematocrit from baseline to peak levels. CONCLUSION: Testosterone administration is associated with suppression of serum hepcidin. Greater increases in hematocrit in older men during testosterone therapy are related to greater suppression of hepcidin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, testosterone fails to directly activate EPO transcription in Hep3B cells, an EPO-secreting cell line that is highly sensitive to hypoxic induction (11)”
From Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point (2014) · cites this paper as [11]
Citations
Cites
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
Self-citationTestosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967
Self-citationCalof, O. M., Singh, A. B., Lee, M. L., Kenny, A. M., Urban, R. J., Tenover, J. L., & Bhasin, S. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.11.1451 · Cited by 728
Self-citationImmunoassay for human serum hepcidin
Ganz, T., Olbina, G., Girelli, D., Nemeth, E., & Westerman, M. (2008) · Blood · doi:10.1182/blood-2008-02-139915 · Cited by 688
Self-citationBhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Mac, R. P., Lee, M., Yarasheski, K. E., Sinha-Hikim, I., Dzekov, C., Dzekov, J., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1184 · Cited by 544
Self-citationEffects of graded doses of testosterone on erythropoiesis in healthy young and older men
Coviello, A. D., Kaplan, B., Lakshman, K. M., Chen, T., Singh, A. B., & Bhasin, S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1692 · Cited by 404
Self-citationIron Sequestration and Anemia of Inflammation
Ganz, T., & Nemeth, E. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.06.001 · Cited by 361
Self-citationProinflammatory state, hepcidin, and anemia in older persons
Ferrucci, L., Semba, R. D., Guralnik, J. M., Ershler, W. B., Bandinelli, S., Patel, K. V., Sun, K., Woodman, R. C., Andrews, N. C., Cotter, R. J., et al. (2010) · Blood · doi:10.1182/blood-2009-02-201087 · Cited by 245
Self-citationAndrogens and erythropoiesis: past and present
Shahani, S., Braga-Basaria, M., Maggio, M., & Basaria, S. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345745 · Cited by 231
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 247
Gender-affirming hormone therapy in the transgender patient: influence on thrombotic risk
King, H., Kelley, T. P., & Shatzel, J. J. (2024) · Hematology · doi:10.1182/hematology.2024000592 · Cited by 16
Interaction of iron status with single nucleotide polymorphisms on incidence of type 2 diabetes
Kim, J., Kim, M. K., Jung, S., Lim, J. E., Shin, M., Kim, Y. J., & Oh, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175681 · Cited by 17
Low testosterone in ageing men: a modifiable risk factor for frailty?
O’Connell, M. D. L., Ravindrarajah, R., Tajar, A., & Wu, F. C. W. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.08.003 · Cited by 16
Khera, M., Miner, M. M., Jaffe, J. S., & Pastuszak, A. W. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.10.019 · Cited by 16
Testosterone replacement therapy and cardiovascular disease
Auerbach, J. M., & Khera, M. (2022) · International Journal of Impotence Research · doi:10.1038/s41443-021-00516-6 · Cited by 16
Samaras, N., Samaras, D., Lang, P. O., Forster, A., Pichard, C., Frangos, E., & Meyer, P. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.11.009 · Cited by 16
Serum hepcidin in infants born after 32 to 37 wk of gestational age
Uijterschout, L., Domellöf, M., Berglund, S. K., Abbink, M., Vos, P., Rövekamp, L. W., Boersma, B., Lagerqvist, C., Hudig, C., van Goudoever, J. B., et al. (2015) · Pediatric Research · doi:10.1038/pr.2015.258 · Cited by 18
Ceccato, F., Occhi, G., Regazzo, D., Randi, M. L., Cecchin, D., Gardiman, M. P., Manara, R., Lombardi, G., Denaro, L., Mantero, F., et al. (2014) · HORMONES · doi:10.1007/bf03401328 · Cited by 16
Testosterone therapy-induced erythrocytosis: can phlebotomy be justified?
Bond, P., Verdegaal, T. J., & Smit, D. L. (2024) · Endocrine Connections · doi:10.1530/ec-24-0283 · Cited by 19
Recommandations pratiques pour la prise en charge du déficit en testostérone
Burte, C., Lejeune, H., Faix, A., Desvaux, P., Almont, T., Cuzin, B., & Huyghe, É. (2021) · The French Journal of Urology · doi:10.1016/j.purol.2020.09.026 · Cited by 15
Why do statins reduce cardiovascular disease more than other lipid modulating therapies?
Schooling, C. M., Yeung, S. L. A., & Leung, G. M. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12342 · Cited by 15
Hernik, A., Szczepanek‐Parulska, E., Filipowicz, D., Abdolall, A. K., Borowczyk, M., Wrotkowska, E., Czarnywojtek, A., Krasiński, Z., & Ruchała, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-52715-3 · Cited by 15
The role of iron in mediating testosterone's effects on erythropoiesis in mice
Guo, W., Ghayda, R. A., Schmidt, P. J., Fleming, M. D., & Bhasin, S. (2020) · The FASEB Journal · doi:10.1096/fj.202000920rr · Cited by 14
Self-citationPagliuca, S., Kulasekararaj, A. G., Eikema, D., Piepenbroek, B., Iftikhar, R., Satti, T. M., Griffin, M., Laurino, M., Küpesiz, A., Bertrand, Y., et al. (2023) · Haematologica · doi:10.3324/haematol.2023.282935 · Cited by 14
The Effect of Testosterone on Cardiovascular Disease
Su, J. J., Park, S. K., & Hsieh, T. (2014) · American Journal of Men s Health · doi:10.1177/1557988314522642 · Cited by 14
Perturbation of the Hematopoietic Profile by Anabolic Androgenic Steroids
Mullen, J., Gårevik, N., Schulze, J. J., Rane, A., Bergman, L. B., & Ekström, L. (2014) · Journal of Hormones · doi:10.1155/2014/510257 · Cited by 14
Iron and Advanced Glycation End Products: Emerging Role of Iron in Androgen Deficiency in Obesity
Chen, S., Yuan, K.-C., Lee, Y., Shih, C., Tseng, S., Tinkov, A. A., Skalny, A. V., & Chang, J. (2020) · Antioxidants · doi:10.3390/antiox9030261 · Cited by 14
Solheim, S. A., Mørkeberg, J., Dehnes, Y., Hullstein, I. R., Juul, A., Upners, E. N., & Nordsborg, N. B. (2020) · Drug Testing and Analysis · doi:10.1002/dta.2803 · Cited by 14
Testosterone therapy and secondary erythrocytosis
White, J. T., Petrella, F., & Ory, J. (2022) · International Journal of Impotence Research · doi:10.1038/s41443-021-00509-5 · Cited by 14
Hypotestosteronaemia in the aging male: should we treat it?
Christe, N., & Meier, C. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14216 · Cited by 14
Czech, A., Kiesz, M., Kiesz, A., Próchniak, T., Różański, P., & Klimiuk, K. (2018) · Annals of Animal Science · doi:10.2478/aoas-2018-0031 · Cited by 13
Androgenic Steroids Use and Abuse
Thirumalai, A., & Anawalt, B. D. (2022) · Urologic Clinics of North America · doi:10.1016/j.ucl.2022.07.008 · Cited by 14
Artz, A. S., Stephens‐Shields, A. J., Bhasin, S., Ellenberg, S. S., Cohen, H. J., & Snyder, P. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa521 · Cited by 14
Self-citationTherapeutic effects of androgens for cachexia
Giovanelli, L., & Quinton, R. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101598 · Cited by 13
Androgen effects on the skeletal muscle
Bhasin, S., Jasuja, R., Serra, C., Singh, R., Storer, T. W., Guo, W., Travison, T. G., & Basaria, S. S. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.010 · Cited by 12
Self-citationWould male hormonal contraceptives affect cardiovascular risk?
Zitzmann, M. (2018) · Asian Journal of Andrology · doi:10.4103/aja.aja_2_18 · Cited by 12
Best, J. C., Gonzalez, D. C., Masterson, T. A., Blachman-Braun, R., Pai, R., & Ramasamy, R. (2020) · Canadian Urological Association Journal · doi:10.5489/cuaj.6651 · Cited by 12
Morabbi, A., & Karimian, M. (2024) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2024.127403 · Cited by 13
Anemia Management Considering the Pathophysiology of Elderly Chronic Kidney Disease Patients
Kuragano, T., Mizusaki, K., Kimura, T., & Nakanishi, T. (2019) · Contributions to nephrology · doi:10.1159/000496528 · Cited by 11
Hypogonadism and cancer survivorship
Faw, C. A., & Brannigan, R. E. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000583 · Cited by 11
Testosterone and Hemoglobin in Hemodialysis Male and Female Patients
Ekart, R., Taskovska, M., Hojs, N. V., Bevc, S., & Hojs, R. (2013) · Artificial Organs · doi:10.1111/aor.12218 · Cited by 11
Anawalt, B. D., O’Connor, K., & Grossmann, M. (2026) · JAMA · doi:10.1001/jama.2026.8526 · Cited by 11
Erythrocytosis Is Rare With Exogenous Testosterone in Gender-Affirming Hormone Therapy
Krishnamurthy, N., Slack, D. J., Kyweluk, M. A., Cullen, O., Kirkley, J., & Safer, J. D. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad651 · Cited by 10
Sex-dependent variation in bone adaptation: from degeneration to regeneration
Chen, S., Patel, J., Katzmeyer, T., & Pei, M. (2025) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2025.04.011 · Cited by 12
Maggio, M. G., Nicolini, F., Cattabiani, C., Beghi, C., Gherli, T., Schwartz, R. S., Valenti, G., & Ceda, G. P. (2012) · Contemporary Clinical Trials · doi:10.1016/j.cct.2012.02.019 · Cited by 10
Menakuru, S. R., Atta, M., Dhillon, V. S., & Salih, A. M. (2023) · Hematology Reports · doi:10.3390/hematolrep15020029 · Cited by 10
Majzoub, A. A., & Shoskes, D. A. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.07.09 · Cited by 10
Anabolic androgenic steroids, an easily forgotten cause of polycythaemia and cerebral infarction
Low, M. S. Y., Vilcassim, S., Fedele, P. L., & Grigoriadis, G. (2016) · Internal Medicine Journal · doi:10.1111/imj.13029 · Cited by 10
Kirkeberg, A., Roaas, T. V., Gundersen, H. S., & Dalen, T. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.858095 · Cited by 11
Tatarian, J., Walcott, Q. A., & Richardson, K. (2022) · LGBT Health · doi:10.1089/lgbt.2022.0027 · Cited by 9
[Effect of hepcidin on iron metabolism in athletes].
Domínguez, R., Garnacho‐Castaño, M. V., & Maté‐Muñoz, J. L. (2014) · PubMed · doi:10.3305/nh.2014.30.6.7440 · Cited by 11
Hepcidin in neoplastic disease.
Nicolae, C. D., Coman, O.-A., Ene, C., Nicolae, I., & Fulga, I. (2013) · Europe PMC (PubMed Central) · Cited by 9
Iron and Testosterone: Interplay and Clinical Implications
Gabrielsen, J. S. (2017) · Current Sexual Health Reports · doi:10.1007/s11930-017-0097-2 · Cited by 9
Androgen therapy in non-gonadal disease
Handelsman, D. J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.018 · Cited by 9
Baker, M. E., Sprague, L. J., Ribecco, C., Ruggeri, B., Lekmine, N., Ludka, C., Wick, I., Soverchia, L., Ubaldi, M., Šášik, R., et al. (2014) · Endocrine Disruptors · doi:10.4161/23273739.2014.969598 · Cited by 8
Testosterone and aging male, a perspective from a developing country
Hoai, B. N., Long, H., Thắng, N. C., Pham, Q. M., & Jannini, E. A. (2023) · The Aging Male · doi:10.1080/13685538.2023.2223712 · Cited by 11
Scala, A., Gender Incongruence Interdisciplinary Group, Graziani, A., Vianello, F., Ferlin, A., & Garolla, A. (2024) · Minerva Endocrinology · doi:10.23736/s2724-6507.24.04171-x · Cited by 7
Kuno, Y., Baba, T., Kuroda, T., Teramoto, M., Hirokawa, N., Endo, T., & Saito, T. (2018) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12213 · Cited by 7
Serum ferritin as a candidate diagnostic biomarker of polycystic ovarian syndrome: a meta-analysis
Tiongco, R. E., Rivera, N. S., Clemente, B., Dizon, D., Salita, C., & Pineda-Cortel, M. R. (2019) · Biomarkers · doi:10.1080/1354750x.2019.1620335 · Cited by 7
Stenvinkel, P., & Barany, P. F. (2012) · Contributions to nephrology · doi:10.1159/000337796 · Cited by 7
Reproductive and Nonreproductive Actions of Testosterone
Bhasin, S., & Jasuja, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65412-0 · Cited by 7
Self-citationNabeyama, T., Suzuki, Y., Yamamoto, K., Sakane, M., Sasaki, Y., Shindo, H., Takita, M., & Kami, M. (2020) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-020-00393-2 · Cited by 10
Yeruva, S. L. H., Nwabudike, S. M., Ogbonna, O. H., & Oneal, P. A. (2015) · Case Reports in Hematology · doi:10.1155/2015/784783 · Cited by 6
Hepcidin Response to Exercise: A Review
Domínguez, R., Vicente-Campos, D., & Chicharro, J. L. (2014) · Endocrinology research and practice. · doi:10.4274/tjem.2438 · Cited by 6
Walczak, J., Bunn, C., Saini, P., Liu, Y. M., Baldea, A. J., & Muthumalaiappan, K. (2020) · Journal of Burn Care & Research · doi:10.1093/jbcr/iraa150 · Cited by 6
Tepe, N., Yemişçi, M., & Karataş, H. (2025) · PubMed · doi:10.14670/hh-18-862 · Cited by 5
Gonzales, G. F. (2025) · Science Progress · doi:10.1177/00368504251387827 · Cited by 6
Wu, F. C. W. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101626 · Cited by 6
A Case of Erythrocytosis in a Patient Treated with an Aromatase Inhibitor for Breast Cancer
Iyengar, A., & Sheppard, D. (2013) · Case Reports in Hematology · doi:10.1155/2013/615189 · Cited by 5
Iron clad: iron homeostasis and the diagnosis of hereditary iron overload
Heeney, M. M. (2014) · Hematology · doi:10.1182/asheducation-2014.1.202 · Cited by 5
Androgen Therapy for Hypogonadism in Men with Chronic Illnesses
Zhang, W., Shabbir, M., & Liu, P. Y. (2017) · Springer eBooks · doi:10.1007/978-3-319-53298-1_19 · Cited by 5
Wu, F.-J., Li, I., Chien, W., Shih, J., Lin, Y., Chuang, C.-M., Cheng, Y., & Kao, L. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034202 · Cited by 5
Hypogonadism management and cardiovascular health
Auerbach, J. M., & Khera, M. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1805917 · Cited by 5
Redefining Unexplained Anemia in Elderly
Eisenga, M. F., Stam, S. P., & Bakker, S. J. L. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.2958 · Cited by 4
Piesanen, J., Kunnas, T. A., & Nikkari, S. T. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102192 · Cited by 4
Testosterone supplementation and stroke in young adults: a review of the literature
Dengri, C., Koriesh, A., Babi, M. A., Mayberry, W., Goldstein, E. D., Pervez, M., & Nouh, A. M. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1422931 · Cited by 4
Developments and challenges for new and emergent preparations for male hypogonadism treatment
Corona, G., Sparano, C., Rastrelli, G., Vignozzi, L., & Maggi, M. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2276760 · Cited by 4
Lethin, K., Aardal, E., Lood, Y., Ekman, B., & Wahlberg, J. (2023) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfad096 · Cited by 5
Chmielewski, P. P., Strzelec, B., Chmielowiec, J., Chmielowiec, K., & Borysławski, K. (2017) · Anthropological Review · doi:10.1515/anre-2017-0012 · Cited by 4
Barton, J. C., & Barton, J. C. (2011) · Acta Haematologica · doi:10.1159/000328045 · Cited by 4
Erythrocytosis as the first manifestation of adrenal carcinoma
Cannavò, L., Zirilli, G., Lima, M., Iaria, G., Luca, F. D., & Valenzise, M. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27685 · Cited by 3
Razak, S., Alam, I., Afsar, T., Abulmeaty, M. M. A., Almajwal, A. M., & Jahan, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00468 · Cited by 3
Barton, J. C., Barton, J. C., & Acton, R. T. (2023) · Cureus · doi:10.7759/cureus.50043 · Cited by 3
Čeponis, J., Wang, C., Swerdloff, R. S., & Liu, P. Y. (2017) · Endocrinology · doi:10.1007/978-3-319-29456-8_11-1 · Cited by 3
Testosterone prescribing in men with depression and anxiety disorders
Javed, Z., Kuo, Y., Temple, J. R., Urban, R. J., Holmes, H. M., & Baillargeon, J. (2020) · Annals of Epidemiology · doi:10.1016/j.annepidem.2020.05.015 · Cited by 3
Testosterone Therapy in Adult-Onset Testosterone Deficiency: Hematocrit and Hemoglobin Changes
Lorde, N., Maarouf, A., Strange, R. C., König, C. S., Hackett, G. I., Haider, A., Haider, K. S., Desnerck, P., Saad, F., & Ramachandran, S. (2021) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2021.0013 · Cited by 3
Lymperaki, E., Stalika, E., Tzavelas, G., Tormpantoni, E., Samara, D., Vagdatli, E., & Tsamesidis, I. (2022) · Clinics and Practice · doi:10.3390/clinpract12030045 · Cited by 4
Han, H., Chen, Y., Zhang, S., Ji, X., Zhu, M., Ma, W., Ge, H., & Chu, H. (2023) · Medicine · doi:10.1097/md.0000000000034838 · Cited by 3
Hierro, anemia y eritrocitosis en gestantes de la altura: riesgo en la madre y el recién nacido
Gonzales, G. F., & Gonzales, C. (2013) · Revista Peruana de Ginecología y Obstetricia · doi:10.31403/rpgo.v58i50 · Cited by 3
Eisenga, M. F., Dullaart, R. P. F., Berger, S. P., Touw, D. J., Bakker, S. J. L., & Gaillard, S. (2017) · American Journal of Hematology · doi:10.1002/ajh.24785 · Cited by 3
Erythrocytosis after liver transplantation: The experience of a university hospital
Cordone, G., Zingone, F., Cardillo, G., Martinelli, V., Pugliese, N., Pellegrini, L., Ciacci, C., & Parrilli, G. (2013) · Liver Transplantation · doi:10.1002/lt.23606 · Cited by 3
Efectos de la suplementación con testosterona sobre el rendimiento en resistencia
Fernández-Díaz, P., & Domínguez, R. (2016) · Revista Andaluza de Medicina del Deporte · doi:10.1016/j.ramd.2015.02.011 · Cited by 3
Čeponis, J., Wang, C., Swerdloff, R. S., & Liu, P. Y. (2017) · Endocrinology · doi:10.1007/978-3-319-44441-3_11 · Cited by 3
Redox on the Clock: Sex-Dependent Dynamics of Xanthine Oxidoreductase Isoforms and Melatonin
Cecerska‐Heryć, E., Zoń, M., Budkowska, M., Serwin, N. M., Michalczyk, A., Goszka, M., Polikowska, A., Wojciuk, B., & Dołęgowska, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311272 · Cited by 2
Carlomagno, F., Tenuta, M., Sansone, A., Rastrelli, G., Sciarra, F., Cangiano, B., Isidori, A. M., Gianfrilli, D., & Krausz, C. G. (2026) · Human Reproduction Update · doi:10.1093/humupd/dmag010 · Cited by 2
Iron Status in Sport Horses: Is It Important for Equine Athletes?
Kiełbik, P., & Witkowska‐Piłaszewicz, O. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125653 · Cited by 3
Banyeh, M., Kangkpi, T., Bani, S. B., Zogli, K. E., Tanko, M. M., Atuahene, P. E., Iddrisu, A. Y., Ekor, C., Akoto, E. O., & Amidu, N. (2023) · Health Science Reports · doi:10.1002/hsr2.1547 · Cited by 2
Dahlquist, D. T. (2016) · cIRcle (University of British Columbia) · doi:10.14288/1.0305021 · Cited by 2
The role of genetically predicted serum iron levels on neurodegenerative and cardiovascular traits
Belbellaj, W., Lona‐Durazo, F., Bodano, C., Busseuil, D., Cyr, M., Fiorillo, E., Mulas, A., Provost, S., Steri, M., Tanaka, T., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-76245-9 · Cited by 1
The intersection of the laboratory and transgender care
Jessen, K., Wijeratne, N. G., & Connell, A. (2025) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2025.2488839 · Cited by 1
Yang, J., Feng, Y., Pan, M., & Zeng, Y. H. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1684162 · Cited by 1
Factors associated with hemoglobin response to hydroxyurea in patients with sickle cell disease
Saber, C., Tukakira, J., Kiriza, N. K., Oluwole, O. B., Castro, L. M. D., Brooks, M. M., Novelli, E. M., & Xu, J. Z. (2026) · Blood Red Cells & Iron · doi:10.1016/j.brci.2026.100048 · Cited by 1
Qi, X., Chen, P., Li, Y., Fan, L., & Yang, D. (2026) · Scientific Reports · doi:10.1038/s41598-026-37641-5 · Cited by 1
Bizjak, D. A., John, L., Munk, M., Reiter, M., Lüders, N., Kirsten, J., Henze, A., & Schulz, S. V. W. (2026) · Sports · doi:10.3390/sports14050200 · Cited by 1
Testosterone-induced erythrocytosis affecting haematocrit prediction of fluid responsiveness
Alagarsamy, F., Khanna, G., Emerson, B., & Oakey, S. (2012) · British Journal of Hospital Medicine · doi:10.12968/hmed.2012.73.4.234a · Cited by 1
Chmiel-Majewska, K., Daniewska, D., Misiorowski, G., Zgliczyński, W., & Gellert, R. (2015) · Postępy Nauk Medycznych · doi:10.5604/08606196.1189835 · Cited by 1
Importance of Testosterone on Adaptation at High Altitude
Gonzales, G. F. (2018) · International Journal of Medical and Surgical Sciences · doi:10.32457/ijmss.2015.043 · Cited by 1
Pietrangelo, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00060-4 · Cited by 1
Shimabukuro, T., Ohmi, C., Nagamitsu, R., Shiraishi, K., & Matsuyama, H. (2021) · The Japanese Journal of Urology · doi:10.5980/jpnjurol.112.81 · Cited by 1
Misadventures in Toxicology: Concentration Matters for Testosterone-Induced Neurotoxicity
Willson, C. (2023) · Toxics · doi:10.3390/toxics11030258 · Cited by 1
Metadata
- Authors
- Bachman, E., Feng, R., Travison, T., Li, M., Olbina, G., Ostland, V., Ulloor, J., Zhang, A., Basaria, S., Ganz, T., Westerman, M., & Bhasin, S.
- Affiliations
- Boston University (US)
- University of Pennsylvania (US)
- Intrinsic LifeSciences (United States) (US)
- University of California, Los Angeles (US)
- Corresponding author
- Bachman, Eric
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-10
- Volume
- 95
- Issue
- 10
- Pages
- 4743-4747
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3050108
- OpenAlex
- W2150542348
- Cited by
- 247
- References
- 19
- Citations by year
- 2026: 18 · 2025: 14 · 2024: 9 · 2023: 16 · 2022: 16 · 2021: 11 · 2020: 23 · 2019: 15 · 2018: 13 · 2017: 18 · 2016: 12 · 2015: 20 · 2014: 15 · 2013: 20 · 2012: 16
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- School of Medicine, Boston University
- Evans Medical Foundation
- National Institutes of Health (5p30ag031679-15)
- National Institute on Aging (U01AG014369, U01 AG14369, P30-AG031679)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- testosterone, hepcidin, testosterone enanthate, hematocrit, hemoglobin, iron regulation, GnRH agonist suppression, dose-response relationship, age differences, men
- MeSH terms
- Adult, Aged, Aging, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Humans, Injections, Male, Middle Aged, Polycythemia, Testosterone, Down-Regulation, Leuprolide, Antimicrobial Cationic Peptides, Young Adult, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review